These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17103075)

  • 41. Sclerosing cholangitis in the era of target chemotherapy: a possible anti-VEGF effect.
    Delis S; Triantopoulou C; Bakoyiannis A; Tassopoulos N; Athanasiou K; Dervenis C
    Dig Liver Dis; 2009 Jan; 41(1):72-7. PubMed ID: 18294938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
    J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective resection of colorectal liver metastases.
    Tamandl D; Gruenberger B; Herberger B; Schoppmann S; Bodingbauer M; Schindl M; Puhalla H; Fleischmann E; Schima W; Jakesz R; Laengle F; Gruenberger T
    Eur J Surg Oncol; 2007 Mar; 33(2):174-82. PubMed ID: 17046194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Management after hepatectomy of colorectal cancer metastases to the liver--intrahepatic arterial infusion chemotherapy and repeated hepatectomy].
    Takanishi K; Matsumoto J; Minami T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1747-51. PubMed ID: 10560386
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Review: incidence and clinical significance of Bevacizumab-related non-surgical and surgical serious adverse events in metastatic colorectal cancer.
    Hompes D; Ruers T
    Eur J Surg Oncol; 2011 Sep; 37(9):737-46. PubMed ID: 21764243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer.
    Yoshioka Y; Uehara K; Ebata T; Yokoyama Y; Mitsuma A; Ando Y; Nagino M
    Surg Today; 2014 Jul; 44(7):1300-6. PubMed ID: 23942819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.
    Kansal KJ; Dominici LS; Tolaney SM; Isakoff SJ; Smith BL; Jiang W; Brock JE; Winer EP; Krop IE; Golshan M
    Breast Cancer Res Treat; 2013 Sep; 141(2):255-9. PubMed ID: 24026859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Pour MZ; Deshwar A; Wang J; Ghasebeh MA; Damaskos C; Rezaee N; Pawlik TM; Wolfgang CL; Kamel IR; Weiss MJ
    J Surg Oncol; 2017 Dec; 116(8):1150-1158. PubMed ID: 28743167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Surgical management of bevacizumab-associated peritonitis due to perforation].
    Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
    Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: the role of anti-VEGF and anti-EGFR antibodies.
    Geva R; Prenen H; Topal B; Aerts R; Vannoote J; Van Cutsem E
    J Surg Oncol; 2010 Dec; 102(8):937-45. PubMed ID: 21165996
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How many patients and how many complications does it take to decide if a drug is safe to use before surgery?
    Kemeny MM
    J Clin Oncol; 2009 Apr; 27(11):1917-8; author reply 1918. PubMed ID: 19255303
    [No Abstract]   [Full Text] [Related]  

  • 52. Management of colorectal liver metastases after complete response to neoadjuvant chemotherapy. A case of computertomography-guided wire marking of the liver tumor.
    Kornprat P; Schöllnast H; Cerwenka H; Werkgartner G; Bernhardt G; Mischinger HJ
    Int J Colorectal Dis; 2009 Jan; 24(1):125-6. PubMed ID: 18682963
    [No Abstract]   [Full Text] [Related]  

  • 53. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab.
    Mahajan D; Miller C; Hirose K; McCullough A; Yerian L
    J Hepatol; 2008 Nov; 49(5):867-70. PubMed ID: 18814928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab.
    Murthy R; Eng C; Krishnan S; Madoff DC; Habbu A; Canet S; Hicks ME
    J Vasc Interv Radiol; 2007 Dec; 18(12):1588-91. PubMed ID: 18057297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indwelling central venous access port insertion during bevacizumab-based therapy.
    Grenader T; Goldberg A; Verstandig A; Shavit L
    Anticancer Drugs; 2010 Aug; 21(7):704-7. PubMed ID: 20517148
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?].
    Zalinski S; Bigourdan JM; Vauthey JN
    J Chir (Paris); 2010 Jan; 147 Suppl 1():S18-24. PubMed ID: 20172201
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of bevacizumab in mild haemophilia B.
    Lambert C; Deneys V; Pothen D; Hermans C
    Thromb Haemost; 2008 May; 99(5):963-4. PubMed ID: 18449429
    [No Abstract]   [Full Text] [Related]  

  • 58. [A retrospective study of oral adverse events with colorectal cancer chemotherapy using bevacizumab].
    Takahashi H; Sato M; Tsukada K; Tsuchiya S; Tanda S
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):959-62. PubMed ID: 21677486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Delayed bile leak with avastin after liver resection for metastatic colorectal cancer.
    Lordan JT; Wilkins M; Karanjia ND
    Hepatogastroenterology; 2011; 58(110-111):1769-70. PubMed ID: 22086700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced recovery in the resection of colorectal liver metastases.
    Dunne DF; Yip VS; Jones RP; McChesney EA; Lythgoe DT; Psarelli EE; Jones L; Lacasia-Purroy C; Malik HZ; Poston GJ; Fenwick SW
    J Surg Oncol; 2014 Aug; 110(2):197-202. PubMed ID: 24715651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.